Medication info

Blue Balance Injection

Prescription medicationInjections정맥
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCupric Sulfate Hydrate›1.57mg / 1mLManganese Sulfate Hydrate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
(주)휴온스
Appearance
A light blue transparent liquid contained in a colorless and transparent vial.
Packaging
10ml vial X 10
Approval status
Active

MFDS item code 201602991 · Notified 2016.05.27

Summary

Main use
Improvement of nutritional status through trace element supply
Who receives it
Adults · Children
Adult administration
To be used according to physician's prescription, adjusting dosage based on plasma trace element levels. The allowable dosage range for intravenous use is as follows: - Zinc: 2.5 to 4 mg daily - Copper: 0.5 to 1.5 mg daily - Manganese: 0.15 to 0.8 mg daily - Chromium: 10 to 15μg daily - Selenium: 20 to 40μg daily Others: - For patients with stable metabolic enteric fluid loss: 12.2 mg/L (enteric fluid loss amount)
Child administration
Pediatric patients under 5 years old: - Zinc: 100μg per kg of body weight daily - Copper: 20μg per kg of body weight daily - Manganese: 2 to 10μg per kg of body weight daily - Chromium: 0.14 to 0.20μg per kg of body weight daily - Selenium

Ingredients

Manufacturer
(주)휴온스

Efficacy & effects

Improvement of nutritional status through trace element supply

View approved original text

When supplying parenteral nutrition, the trace elements zinc, copper, manganese, selenium, and chromium are provided together to improve the patient’s nutritional status and help normalize metabolism and immune function. These trace elements play an essential role as components of various enzymes in the body and are critical for recovery and maintenance of health. Therefore, the supply of trace elements supports effective treatment during the parenteral nutrition process.

How it is given

Adult administration

To be used according to physician's prescription, adjusting dosage based on plasma trace element levels. The allowable dosage range for intravenous use is as follows: - Zinc: 2.5 to 4 mg daily - Copper: 0.5 to 1.5 mg daily - Manganese: 0.15 to 0.8 mg daily - Chromium: 10 to 15μg daily - Selenium: 20 to 40μg daily Others: - For patients with stable metabolic enteric fluid loss: 12.2 mg/L (enteric fluid loss amount)

Child administration

Pediatric patients under 5 years old: - Zinc: 100μg per kg of body weight daily - Copper: 20μg per kg of body weight daily - Manganese: 2 to 10μg per kg of body weight daily - Chromium: 0.14 to 0.20μg per kg of body weight daily - Selenium

Precautions

This drug should not be administered to premature infants and newborns, as it contains benzyl alcohol which can cause fatal respiratory issues in premature infants. This drug should be diluted before direct intravenous injection to prevent the risk of phlebitis. Because it is a hypotonic solution, it should only be used in mixed injection forms and should not be administered alone. If any toxic symptoms appear during administration, the injection should be immediately discontinued. This drug contains aluminum, which can pose a toxicity risk if administered for a prolonged period to patients with impaired renal function or to premature infants. Before administration, the patient's condition and metabolic requirements must be accurately assessed by a physician, and blood levels of trace elements should be regularly monitored to adjust the dosage. Patients with impaired renal or biliary function require special caution, as the trace elements in this drug can accumulate in the body and lead to toxicity. The safety of this drug has not been sufficiently established in pregnant women or women of childbearing potential; it should only be administered when the therapeutic benefits outweigh the risks. In cases of overdose, toxic symptoms of trace elements such as zinc, copper, chromium, and selenium may occur, necessitating immediate treatment and detoxification. This drug must be used strictly under a physician's prescription, and when adding it to non-oral nutritional solutions, aseptic conditions must be maintained and the solution should be checked for discoloration or sediment.

Side effects and when to seek care immediately

Serious side effects

  • Hypotension
  • pulmonary edema
  • jaundice
  • decreased urine output
  • severe edema
  • coma

Mild side effects

  • Sweating
  • decreased consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • diarrhea
  • vomiting
  • hair loss
  • nail weakness
  • dermatitis
Show 14 more
  • dental damage
  • gastrointestinal disturbances
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlic smell during breathing
  • lethargy
  • behavioral changes
  • photophobia
  • nausea
  • ulcers
  • coma
  • metallic taste

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent exposure to air or moisture. The storage temperature should be kept between 15 to 30 degrees Celsius to maintain the drug’s effectiveness for a longer period.

Appearance and packaging

Appearance

A light blue transparent liquid contained in a colorless and transparent vial.

Package unit

10ml vial X 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.